News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Early-Stage Biotech Microlin Bio Postpones $28 Million IPO


8/7/2014 7:09:52 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Microlin Bio, a diagnostic and therapeutics biotech focusing on microRNA and its role in oncology, postponed its IPO on Wednesday. The recently-formed biotech had previously revised its terms several times, most recently adding warrants. It had planned to raise $28 million by offering 5.5 million units at a range of $4.50 to $5.50, and would have commanded a market cap of $51 million.

Help employers find you! Check out all the jobs and post your resume.

Read at Nasdaq


comments powered by Disqus
Nasdaq
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES